Article
New Products & Services
Raritan, NJ-The FDA has approved a once-a-day liquid formulation of the fluoroquinone antibiotic levofloxacin (Levaquin), from Ortho-McNeil Pharmaceutical, Inc. Levofloxacin is indicated for the treatment of a number of infections, including complicated and uncomplicated urinary tract infections, chronic bacterial prostatitis, and acute pyelonephritis.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Related Videos
Related Content
